8-K current report · filed Oct 19, 2026

SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8-K Current Report: October 19, 2026

Item 2.02Item EX-99.11SUPN overview

Short answer

SUPERNUS PHARMACEUTICALS, INC. (SUPN) filed an 8-K current report with the SEC on October 19, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.11 (Exhibit EX-99.11). Supernus scheduled third-quarter 2026 results for October 29, 2026, after market close.

SUPERNUS PHARMACEUTICALS, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Supernus scheduled third-quarter 2026 results for October 29, 2026, after market close
  • Management conference call and webcast set for 4:30 p.m. ET on October 29
  • Investors should watch the release for operating performance and business updates, with details in Exhibit 99.1

Item EX-99.11 · Exhibit EX-99.11

  • Third-quarter 2026 results scheduled after market close on October 29, 2026
  • Management conference call at 4:30 p.m. ET, providing guidance and business updates
  • Investor focus: prescription trends, Sage-acquired products, profitability, and pipeline progress
  • Webcast replay available for 60 days, enabling post-release review of management commentary

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other SUPERNUS PHARMACEUTICALS, INC. 8-K filings

Get the next SUPN 8-K as it lands

Follow SUPN for push alerts, or ask the research agent what this filing means.